迈克生物：深化人工智能技术在体外诊断领域的应用

Core Viewpoint - The company is actively integrating AI technologies, such as DeepSeek, into its clinical testing and auxiliary detection systems to enhance efficiency and accuracy in medical data research [1] Group 1: AI Integration - The company utilizes various AI models, including DeepSeek and Tongyi Qianwen, to improve detection efficiency and accuracy in different testing scenarios [1] - The company aims to deepen the application of AI technology in the in vitro diagnostic field, promoting product innovation to meet market demands for efficient and precise testing [1] Group 2: Market Response - The company expresses gratitude for investor support and emphasizes the importance of rational investment decisions regarding AI and medical-related business developments [1]